8-K: Horizon Tech Finance Q2 2025 Results & Merger

Sentiment:

Quarterly Report


Horizon Technology Finance reports a decline in Q2 2025 net investment income and NAV per share, alongside a significant merger announcement with Monroe Capital Corporation.

Capital raiseIncreased commitment of senior secured debt facility by $100 million to enable the company's financing subsidiary to issue up to $200 million of secured notes.Amended a facility with a large U.S. insurance company to increase the commitment by $100.0 million.Holders of a portion of the $20.0 million 7.125% convertible notes due 2031 converted $12.5 million in outstanding principal into common stock during Q2 2025.
Worse than expectedNet Investment Income per share decreased from $0.36 in Q2 2024 to $0.28 in Q2 2025.Net Asset Value per share significantly declined from $9.12 as of June 30, 2024, to $6.75 as of June 30, 2025.The company shifted from a net realized gain on investments of $2.5 million in Q2 2024 to a net realized loss of $9.3 million in Q2 2025.Net unrealized appreciation of $24.5 million in Q2 2024 turned into net unrealized depreciation of $22.2 million in Q2 2025.The net decrease in net assets resulting from operations worsened from ($0.26) per share in Q2 2024 to ($0.50) per share in Q2 2025.The number and fair value of high-risk (credit rating 1) debt investments increased from December 31, 2024, to June 30, 2025.The net debt to equity leverage ratio of 122% is modestly above the company's 120% targeted leverage.

Summary

  • Net investment income (NII) for Q2 2025 was $11.4 million, or $0.28 per share, a decrease from $12.9 million, or $0.36 per share, in the prior-year period.
  • Net asset value (NAV) per share stood at $6.75 as of June 30, 2025, down from $9.12 as of June 30, 2024.
  • The total investment portfolio was valued at $622.7 million as of June 30, 2025.
  • The annualized portfolio yield on debt investments for the quarter was 15.8%.
  • Horizon funded seven loans totaling $59.7 million during the quarter.
  • The company experienced liquidity events from seven portfolio companies.
  • A merger agreement with Monroe Capital Corporation (MRCC) was announced, subject to shareholder approvals and other closing conditions.
  • Net realized loss on investments was $9.3 million, or $0.23 per share, in Q2 2025, compared to a net realized gain of $2.5 million, or $0.07 per share, in Q2 2024.
  • Net unrealized depreciation on investments was $22.2 million, or $0.54 per share, in Q2 2025, compared to net unrealized appreciation of $24.5 million, or $0.69 per share, in the prior-year period.
  • Undistributed spillover income was $0.94 per share as of June 30, 2025.
  • Monthly distributions of $0.11 per share were declared for October, November, and December 2025, totaling $0.33 per share.
  • The net debt to equity leverage ratio was 122% as of June 30, 2025, modestly above the company's 120% targeted leverage.

Sentiment

Score: 4

Explanation: While the merger announcement and consistent distributions offer some positive outlook and stability, the significant declines in key financial metrics (NII, NAV, realized/unrealized losses) and the increase in high-risk loans indicate a challenging operational quarter. The positive future outlook is contingent on the merger closing and successful navigation of the venture capital environment.

Positives

  • The annualized portfolio yield on debt investments remained strong at 15.8% for the quarter.
  • The company increased its senior secured debt facility commitment by $100 million, enabling its financing subsidiary to issue up to $200 million of secured notes.
  • Seven portfolio companies experienced liquidity events, including significant loan prepayments and warrant redemptions.
  • Consistent monthly distributions of $0.11 per share were declared through December 2025, totaling $0.33 per share.
  • The announced merger with Monroe Capital Corporation (MRCC) is expected to significantly increase Horizon's size, scale, and capital base, expanding its venture lending solutions.
  • The stock repurchase program authorization was increased from $5.0 million to $10.0 million.
  • The purchase of remaining assets of Powerscourt Investments XXV, LP for $22.5 million is expected to be accretive to net asset value in the third quarter.

Negatives

  • Net Investment Income (NII) per share decreased to $0.28 in Q2 2025 from $0.36 in Q2 2024.
  • Net Asset Value (NAV) per share significantly declined to $6.75 as of June 30, 2025, from $9.12 as of June 30, 2024.
  • The company recorded a net realized loss on investments of $9.3 million in Q2 2025, a reversal from a net realized gain of $2.5 million in the prior-year period.
  • Net unrealized depreciation on investments was $22.2 million in Q2 2025, compared to net unrealized appreciation of $24.5 million in the prior-year period.
  • The net decrease in net assets resulting from operations worsened to $20.8 million ($0.50 per share) in Q2 2025 from $9.1 million ($0.26 per share) in Q2 2024.
  • The net debt to equity leverage ratio of 122% is slightly above the company's 120% targeted leverage.
  • The number of debt investments with an internal credit rating of 1 (highest risk of loss of principal) increased to five with an aggregate fair value of $26.9 million as of June 30, 2025, from four with an aggregate fair value of $10.5 million as of December 31, 2024.

Risks

  • The net asset value was impacted by the ongoing challenging venture capital environment.
  • There is potential for future loss of principal for loans with an internal credit rating of 2, although no loss is currently anticipated.
  • Loans with an internal credit rating of 1 represent deteriorating credit quality and a high degree of risk of loss of principal, and the fair value of such loans increased.
  • There is no assurance that additional lenders will make commitments under the Key Facility to increase the total loan commitment.
  • The announced merger with Monroe Capital Corporation (MRCC) is subject to certain shareholder approvals and the satisfaction of other closing conditions, meaning it is not guaranteed to close.
  • Forward-looking statements involve a number of risks and uncertainties, and actual results may differ materially from those projected.

Future Outlook

The announced merger with Monroe Capital Corporation (MRCC) is expected to significantly increase Horizon's size, scale, and capital base, expanding its ability to provide venture lending solutions, including to small-cap public market companies. Management anticipates the merger will better position the company to win larger venture lending transactions and support innovative businesses. Despite the challenging venture capital environment, the company expects significant growth in 2026 and aims to generate attractive and sustainable risk-adjusted returns for shareholders over the longer term.

Management Comments

  • "We are excited at the announcement of our forthcoming merger with MRCC. Upon closing, HRZN will significantly increase its size, scale and capital base, while continuing to receive the active backing of a premier asset manager in Monroe Capital."
  • "Once completed, the merger will significantly expand our ability to provide venture lending solutions, including to small-cap public market companies, which is an attractive and renewed focus for investment. We expect the merger will better position us to win larger venture lending transactions and to support innovative businesses shaping the future."
  • "For the quarter, our net asset value was impacted in large part by the ongoing challenging venture capital environment. We remain sharply focused on navigating the current environment and believe this focus, along with completing the merger, will enable us to significantly grow in 2026 and, over the longer-term, generate attractive and sustainable risk-adjusted returns for our shareholders."

Industry Context

The filing highlights the persistent challenges within the venture capital environment, which has negatively impacted Horizon's net asset value. The strategic merger with Monroe Capital Corporation (MRCC) represents a significant move to enhance scale and capital, positioning Horizon more competitively within the specialty finance and venture lending sectors. This expansion, particularly into small-cap public market companies, suggests a proactive approach to diversify and capture new growth opportunities amidst evolving market dynamics and potential industry consolidation.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results to benchmark against industry standards.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Stock Repurchase Program Extension and IncreaseThe Board of Directors extended the company's previously authorized stock repurchase program until June 30, 2026, and increased the maximum repurchase amount from $5.0 million to $10.0 million, with purchases limited to 2% of shares outstanding and when shares trade below 90% of NAV per share.2025-08-05Potentially positive for shareholder value by reducing share count and supporting share price when trading below NAV, signaling management's belief in undervaluation.

Related Party Transactions

  • Horizon Technology Finance Corporation is an affiliate of Monroe Capital.
  • The company announced a merger agreement with Monroe Capital Corporation (MRCC), which is also an affiliate of Monroe Capital.

Stakeholder Impact

  • Shareholders experienced a decline in NAV per share and NII per share in Q2 2025, but may benefit from the strategic merger, consistent distributions, and increased stock repurchase program.
  • Portfolio companies continue to receive secured loans and venture lending solutions, with several experiencing liquidity events.
  • Creditors and lenders benefit from increased debt facilities and extended maturity dates, providing greater capital flexibility for the company.

Next Steps

  • Completion of the merger with Monroe Capital Corporation (MRCC), subject to shareholder approvals and other closing conditions.
  • Continued focus on navigating the current challenging venture capital environment.
  • Expected significant growth in 2026.
  • Continued generation of attractive and sustainable risk-adjusted returns for shareholders over the longer-term.
  • Potential future stock repurchases under the extended program (up to $10.0 million).
  • Reporting of Q3 financial results, which are expected to reflect the accretive impact of the Powerscourt Investments XXV, LP asset purchase.

Key Dates

DateDescription
2024-10-17Entered into a note purchase agreement for $20.0 million aggregate principal of 7.125% convertible notes due 2031.
2024-11-15Reinvestment period of the 2022 Notes ended.
2025-04-25Amended NYL Facility to extend the investment period to June 2027; Board of directors extended the stock repurchase program until June 30, 2026 or the repurchase of $5.0 million of common stock.
2025-05-23Amended facility with a large U.S. insurance company to extend the investment period to June 2028, the maturity date to June 2034, and increase the commitment by $100.0 million.
2025-06-30End of the second quarter, financial results reported as of this date.
2025-07-01Received proceeds of $2.7 million from the exercise of warrants in Kate Farms, Inc.
2025-07-10Holders converted $3.75 million in outstanding principal of the 2031 Convertible Notes into 496,256 shares of common stock.
2025-07-18Noodle Partners, Inc. prepaid its outstanding principal balance of $16.7 million on its venture loan; received a principal paydown of $2.0 million on venture loans to Tallac Therapeutics, Inc.
2025-07-29Pivot Bio, Inc. prepaid its outstanding principal balance of $10.0 million on its venture loan.
2025-07-30Native Microbials, Inc. prepaid its outstanding principal balance of $3.5 million on its venture loan.
2025-08-05Board of Directors authorized an increase in the maximum amount of shares that can be repurchased to up to $10.0 million; declared monthly distributions of $0.11 per share payable in October, November, and December 2025.
2025-08-06Purchased substantially all of the remaining assets of Powerscourt Investments XXV, LP for $22.5 million.
2025-08-07Entered into a Merger Agreement with Monroe Capital Corporation (MRCC); date of the 8-K filing and press release.
2025-09-17Ex-Dividend Date and Record Date for the October 15, 2025 distribution.
2025-10-15Payment Date for the $0.11 per share distribution.
2025-10-16Ex-Dividend Date and Record Date for the November 14, 2025 distribution.
2025-11-14Payment Date for the $0.11 per share distribution.
2025-11-17Ex-Dividend Date and Record Date for the December 16, 2025 distribution.
2025-12-16Payment Date for the $0.11 per share distribution.
2026Expected significant growth.
2026-06-30Extended stock repurchase program expiration date.
2027-06Extended investment period for NYL Facility.
2028-06Extended investment period for facility with a separate large U.S. insurance company.
2030-11-15Stated maturity of the 2022 Notes.
2031Maturity of the 7.125% convertible notes.
2034-06Extended maturity date for facility with a separate large U.S. insurance company.

Recommendation

hold

While the significant declines in NAV and NII, coupled with increased realized/unrealized losses and higher-risk loans, present clear negatives, the announced merger with Monroe Capital Corporation is a transformative event that could significantly enhance the company's scale, capital base, and future growth opportunities. The consistent dividend payout and increased share repurchase authorization also provide some support. Investors should hold to see the outcome and integration of the merger, as its success will be key to future performance, but the current quarter's financial deterioration warrants caution against a 'buy' recommendation.

Keywords

Venture Debt, Specialty Finance, Technology, Life Science, Healthcare Information, Sustainability, Secured Loans, Private Equity, Venture Capital, SEC Filing, Financial Results, Merger, Monroe Capital, HRZN, MRCC, Net Investment Income, Net Asset Value, Portfolio Yield, Distributions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.